🟢 Cuprina Holdings is trading 9.7% up in pre-market with no identified catalyst

Cuprina Holdings is trading 9.7% up in pre-market at $2.04; its cause is unclear.

• The October 16 close was $1.90; reviewed sources showed no fresh company-specific announcement explaining the October 19 move.
• The biomedical and biotechnology business focuses on chronic wound care, not crypto; cryptocurrency moves are not an established direct explanation.
• U.S. index futures are higher, while Asian markets and European futures are under pressure. The October 2 clinic-acquisition announcement does not establish a reason for this move.